EYD-002

N/A

Report date: 2025/01/26 19:33:20
NME

Base Information

Drug NameEYD-002
Drug Alias NameFms-like tyrosine kinase 3inhibitors (Eydis Bio Inc)EYD-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEydisBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesEydisBio Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A